Breaking News

Alvogen Appoints Americas Head

October 31, 2013

Alkins brings 25 years of commercial experience

Darren Alkins has been appointed president of Alvogen Americas and will become a member of the executive board. Mr. Alkins will be leading Alvogen’s sales, marketing and business development efforts in North and South America. He will also be responsible for Alvogen’s third party business units in the U.S., including Norwich Pharma Services, a contract manufacturing and clinical research organization based in Norwich, NY.
 
Mr. Alkins brings 25 years of commercial experience in brand and generic sales and marketing, as well as third party business development. Most recently, he led the business development and alliance management team for Teva Pharmaceuticals, driving key initiatives developing new and existing business for the company in the U.S. He also served as senior vice president of corporate development at Stiefel Laboratories and president of Glades Pharmaceuticals. He began his career at Bristol-Myers Squibb, and was promoted through various sales, marketing, operations and business development functions.
 
“I am delighted to welcome Darren to the executive board, a role for which he is well prepared through his extensive industry experience. With more than 25 years of commercial experience in both branded and generic pharmaceuticals, Darren’s successful history driving key organizational initiatives, expertise and leadership will help lead Alvogen into our next phase of growth,” said Robert Wessman, chairman and chief executive officer of Alvogen.
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision